Cargando…

3D Printing of Personalised Carvedilol Tablets Using Selective Laser Sintering

Selective laser sintering (SLS) has drawn attention for the fabrication of three-dimensional oral dosage forms due to the plurality of drug formulations that can be processed. The aim of this work was to employ SLS with a CO(2) laser for the manufacturing of carvedilol personalised dosage forms of v...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabriz, Atabak Ghanizadeh, Gonot-Munck, Quentin, Baudoux, Arnaud, Garg, Vivek, Farnish, Richard, Katsamenis, Orestis L., Hui, Ho-Wah, Boersen, Nathan, Roberts, Sandra, Jones, John, Douroumis, Dennis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537056/
https://www.ncbi.nlm.nih.gov/pubmed/37765199
http://dx.doi.org/10.3390/pharmaceutics15092230
_version_ 1785113013313863680
author Tabriz, Atabak Ghanizadeh
Gonot-Munck, Quentin
Baudoux, Arnaud
Garg, Vivek
Farnish, Richard
Katsamenis, Orestis L.
Hui, Ho-Wah
Boersen, Nathan
Roberts, Sandra
Jones, John
Douroumis, Dennis
author_facet Tabriz, Atabak Ghanizadeh
Gonot-Munck, Quentin
Baudoux, Arnaud
Garg, Vivek
Farnish, Richard
Katsamenis, Orestis L.
Hui, Ho-Wah
Boersen, Nathan
Roberts, Sandra
Jones, John
Douroumis, Dennis
author_sort Tabriz, Atabak Ghanizadeh
collection PubMed
description Selective laser sintering (SLS) has drawn attention for the fabrication of three-dimensional oral dosage forms due to the plurality of drug formulations that can be processed. The aim of this work was to employ SLS with a CO(2) laser for the manufacturing of carvedilol personalised dosage forms of various strengths. Carvedilol (CVD) and vinylpyrrolidone-vinyl acetate copolymer (Kollidon VA64) blends of various ratios were sintered to produce CVD tablets of 3.125, 6.25, and 12.5 mg. The tuning of the SLS processing laser intensity parameter improved printability and impacted the tablet hardness, friability, CVD dissolution rate, and the total amount of drug released. Physicochemical characterization showed the presence of CVD in the amorphous state. X-ray micro-CT analysis demonstrated that the applied CO(2) intensity affected the total tablet porosity, which was reduced with increased laser intensity. The study demonstrated that SLS is a suitable technology for the development of personalised medicines that meet the required specifications and patient needs.
format Online
Article
Text
id pubmed-10537056
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105370562023-09-29 3D Printing of Personalised Carvedilol Tablets Using Selective Laser Sintering Tabriz, Atabak Ghanizadeh Gonot-Munck, Quentin Baudoux, Arnaud Garg, Vivek Farnish, Richard Katsamenis, Orestis L. Hui, Ho-Wah Boersen, Nathan Roberts, Sandra Jones, John Douroumis, Dennis Pharmaceutics Article Selective laser sintering (SLS) has drawn attention for the fabrication of three-dimensional oral dosage forms due to the plurality of drug formulations that can be processed. The aim of this work was to employ SLS with a CO(2) laser for the manufacturing of carvedilol personalised dosage forms of various strengths. Carvedilol (CVD) and vinylpyrrolidone-vinyl acetate copolymer (Kollidon VA64) blends of various ratios were sintered to produce CVD tablets of 3.125, 6.25, and 12.5 mg. The tuning of the SLS processing laser intensity parameter improved printability and impacted the tablet hardness, friability, CVD dissolution rate, and the total amount of drug released. Physicochemical characterization showed the presence of CVD in the amorphous state. X-ray micro-CT analysis demonstrated that the applied CO(2) intensity affected the total tablet porosity, which was reduced with increased laser intensity. The study demonstrated that SLS is a suitable technology for the development of personalised medicines that meet the required specifications and patient needs. MDPI 2023-08-29 /pmc/articles/PMC10537056/ /pubmed/37765199 http://dx.doi.org/10.3390/pharmaceutics15092230 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Tabriz, Atabak Ghanizadeh
Gonot-Munck, Quentin
Baudoux, Arnaud
Garg, Vivek
Farnish, Richard
Katsamenis, Orestis L.
Hui, Ho-Wah
Boersen, Nathan
Roberts, Sandra
Jones, John
Douroumis, Dennis
3D Printing of Personalised Carvedilol Tablets Using Selective Laser Sintering
title 3D Printing of Personalised Carvedilol Tablets Using Selective Laser Sintering
title_full 3D Printing of Personalised Carvedilol Tablets Using Selective Laser Sintering
title_fullStr 3D Printing of Personalised Carvedilol Tablets Using Selective Laser Sintering
title_full_unstemmed 3D Printing of Personalised Carvedilol Tablets Using Selective Laser Sintering
title_short 3D Printing of Personalised Carvedilol Tablets Using Selective Laser Sintering
title_sort 3d printing of personalised carvedilol tablets using selective laser sintering
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537056/
https://www.ncbi.nlm.nih.gov/pubmed/37765199
http://dx.doi.org/10.3390/pharmaceutics15092230
work_keys_str_mv AT tabrizatabakghanizadeh 3dprintingofpersonalisedcarvediloltabletsusingselectivelasersintering
AT gonotmunckquentin 3dprintingofpersonalisedcarvediloltabletsusingselectivelasersintering
AT baudouxarnaud 3dprintingofpersonalisedcarvediloltabletsusingselectivelasersintering
AT gargvivek 3dprintingofpersonalisedcarvediloltabletsusingselectivelasersintering
AT farnishrichard 3dprintingofpersonalisedcarvediloltabletsusingselectivelasersintering
AT katsamenisorestisl 3dprintingofpersonalisedcarvediloltabletsusingselectivelasersintering
AT huihowah 3dprintingofpersonalisedcarvediloltabletsusingselectivelasersintering
AT boersennathan 3dprintingofpersonalisedcarvediloltabletsusingselectivelasersintering
AT robertssandra 3dprintingofpersonalisedcarvediloltabletsusingselectivelasersintering
AT jonesjohn 3dprintingofpersonalisedcarvediloltabletsusingselectivelasersintering
AT douroumisdennis 3dprintingofpersonalisedcarvediloltabletsusingselectivelasersintering